Robert Lechleider insider trades
Open-market stock purchases and sales by Robert Lechleider, Chief Medical Officer at Immunome Inc, from SEC Form 4 filings since Oct 27, 2023.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +152%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 23, 2026 | IMNM Immunome Inc | Bought (not open market) | — |
| Jul 23, 2026 | IMNM Immunome Inc | Bought (not open market) | — |
| Jul 2, 2026 | IMNM Immunome Inc | Sold | $499K |
| Jul 2, 2026 | IMNM Immunome Inc | Sold | $369K |
| Jul 2, 2026 | IMNM Immunome Inc | Sold | $377K |
| Jul 2, 2026 | IMNM Immunome Inc | Bought (not open market) | — |
| Jun 25, 2026 | IMNM Immunome Inc | Sold | $794K |
| Jun 25, 2026 | IMNM Immunome Inc | Sold | $298K |
| Jun 25, 2026 | IMNM Immunome Inc | Bought (not open market) | — |
Companies traded
- IMNM Immunome Inc: 1 buy, 5 sales, last Jul 23, 2026